Aileron Therapeutics Inc. buy me8
Start price
11.01.21
/
0%
€1.50
Target price
11.01.22
-
Performance (%)
-6.67%
End price
29.01.21
€1.40
Summary
This prediction ended on 29.01.21 with a price of €1.40. With a performance of -6.67%, the BUY prediction by me8 finished with a loss. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aileron Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -0.870% | -1.700% | 10.560% | 13.129% |
| iShares Nasdaq 100 | -5.561% | -3.604% | 34.335% | 39.856% |
| iShares Nikkei 225® | -6.138% | -7.732% | 16.215% | 0.044% |
| iShares S&P 500 | -3.141% | -2.011% | 24.534% | 39.859% |
According to me8 what are the pros and cons of Aileron Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Good culture
Innovative
Cons
Growths slower than the competition
Comments by me8 for this prediction
In the thread Aileron Therapeutics Inc. diskutieren
Buy Aileron Therapeutics Inc.